This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slid 3.1% to $1.86 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.7% to 17,844.24 and Dow Jones Industrial Average falling 0.2% to 41,218.83.
Inovio Pharmaceuticals Inc. closed 86.2% below its 52-week high of $13.44, which the company reached on May 16th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 0.7% to $155.00, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 1.36% to $23.87.
Trading volume totaled 242,218, compared to the 50-day average of 671,632.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 05, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.